New and inexpensive for breast cancer: Palbocent
To fight breast cancer, new therapies and drugs are being developed every day. Pharmaceutical corporation Pfizer recently presented a substance that has shown excellent results in the fight against breast cancer. The efficacy was found to be high in the treatment of metastatic and locally advanced cancers.
The substance is called palbociclib. During the research phase, the optimal dose of palbociclib was identified, after which Pfizer launched a new effective drug, Ibrance, on the market. The drug was approved by the World Health Organization as essential, thanks to which Ibranza is widely distributed in more than 85 countries. The drug gained popularity and a reputation as an effective drug, which was noted by the world medical community in the form of the Galen Prize in the category "Best Pharmaceutical Product of the Year 2016".
For several years of use by oncologists, Ibransa has become one of the most popular drugs in the treatment of breast cancer. However, many patients cannot afford to purchase such an expensive medication. Taking into account the factors of cost and availability of Ibransa for residents of non-European countries, the WHO decided to transfer the formulation of the drug to companies in Bangladesh and some other countries.
Palbocent - Generic Ibransa
Since Ibrance belongs to the category of essential drugs, the formulation and license for the production of generics is transferred only to reliable manufacturers. One of these companies is Incepta Pharmaceuticals Ltd. At this Bangladeshi enterprise, the production of a complete analogue of Ibrana, the drug Palbocent, was launched.
Palbocent is a complete replica of Ibransa. It contains the same amount of active ingredient - palbociclib - 125 mg, thanks to which the effectiveness of Palbocent is not inferior to the original. The action of Palbocent is to inhibit the protein kinase protein of cancer cells, which inhibits the growth of tumors, destroying them from the inside. Palbocent is produced in the same way as the original, in hard gelatin capsules, 21 pieces in a blister, packed in a branded cardboard box with holograms, where the production and expiration dates are indicated.
According to the doctors who prescribed Palbocent and Ibransa, the drug helps to significantly slow down the progression of the disease, reduce symptoms and improve the quality of life of patients.
The Palbocent drug is available to patients in all regions and cities of Russia, to order the drug, consult a specialist in our pharmacy.